Financials

News Ideas Discussions Technicals Seasonals

DANCAN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

DanCann Pharma A/S is a biopharmaceutical company, which engages in the business of discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in various disease areas. It operates under the Biomaterials and Import and Export of Medical Cannabis Products segments. The company was founded by Jeppe Krog Rasmussen on March 20, 2018 and is headquartered in Ansager, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

DANCAN has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company